Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi

Diseases caused by fungi can occur in healthy people, but immunocompromised patients are the major risk group for invasive fungal infections. Cases of fungal resistance and the difficulty of treatment make fungal infections a public health problem. This review explores mechanisms used by fungi to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Parente-Rocha, Juliana Alves, Bailão, Alexandre Melo, Amaral, André Correa, Taborda, Carlos Pelleschi, Paccez, Juliano Domiraci, Borges, Clayton Luiz, Pereira, Maristela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485324/
https://www.ncbi.nlm.nih.gov/pubmed/28694566
http://dx.doi.org/10.1155/2017/9870679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485324/
https://www.ncbi.nlm.nih.gov/pubmed/28694566
http://dx.doi.org/10.1155/2017/9870679

Ejemplares similares